ARCHIVES

Book Review: In Memoir Written to Avoid Doing Time, Disgraced Exec Reflects on BMS Heyday

This article is from The Cancer Letter archive.

Vol. 38 No. 27 | July 6, 2012

Download PDF Visit The Full Archive

Related Articles

ACS Unveils Plan For Combating Tobacco Marketing

May 18, 1990

Funding Opportunities: NCI Accepts apploications For Cooperative Group Awards

February 12, 1999

Fourteen Immunology RFPs Announced, NCI will Have Eight More Immunodiagnosis; $43 Million Budgeted

September 6, 1974

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

In Brief

February 7, 2014

NIH-funded HapMap consortium publishes first phase of catalog.

October 28, 2005